Cancer Therapy News and Research

RSS

Lifestyle changes can play a considerable role in influencing risk of cancer later in life

Lifestyle changes can play a considerable role in influencing the risk of developing cancer later in life. The key negative factors include smoking, lack of exercise and being overweight.

26 Sep 2012

PsiOxus initiates ColoAd1 phase I/II trial in metastatic solid tumours

PsiOxus Therapeutics, Ltd. has treated the first patient in its phase I/II clinical trial of ColoAd1for the treatment of metastatic solid tumours.

26 Sep 2012

IV connectors can play a crucial role in protecting patients from infections and other complications

Medical devices known as IV connectors, through which intravenous medication and nutrition are provided to a patient, can play a crucial role in protecting patients from life-threatening infections and other complications. But some types of connectors are much more prone to dangerous complications, according to a recent poster presentation at an international meeting of oncology nurses, the 17th International Conference on Cancer Nursing, held Sept. 9-13 in Prague, Czech Republic.

26 Sep 2012

ProMedica invests $710,000 in new cancer and infusion center in Fostoria, Ohio

Cancer patients in Fostoria, Ohio, now have access to advanced cancer treatment and protocols close to home. The ProMedica Cancer Institute has invested $710,000 in a new cancer and infusion center in Fostoria, Ohio. The rural community has a population of 13,000 residents.

25 Sep 2012

Cancer-related medical costs to more than double in some states in less than eight years

Cancer-related medical costs, already a significant portion of overall medical expenses in the United States, will more than double in some states in less than eight years, according to a new study by researchers from RTI International and the Centers for Disease Control and Prevention.

25 Sep 2012

Aromatase inhibitors impact sex life of postmenopausal women with breast cancer

Women treated for breast cancer after menopause with aromatase inhibitors have very high levels of sexual difficulties, including low interest, insufficient lubrication, and pain with intercourse. It is an important and underestimated problem, say the authors of a study published online in Menopause, the journal of the North American Menopause Society.

25 Sep 2012

Endorectal MRI helps assess eligibility of men with prostate cancer for active surveillance

PSA screening has resulted in improved prostate cancer survival, but the high rate of diagnosis and treatment side effects raise concerns about overtreatment. In the quest to prevent overtreatment, "active surveillance" has emerged as a plausible option, encouraged for men whose tumors may not need immediate treatment and may never progress to more serious illness. Appropriate criteria for selecting patients for active surveillance are continuously debated.

25 Sep 2012

ESMO Designated Center of Integrated Oncology and Palliative Care accreditation for 16 new centers

The European Society for Medical Oncology has awarded ESMO Designated Center of Integrated Oncology and Palliative Care accreditation to 16 new oncology centers. The centers will receive the acknowledgment at the ESMO 2012 Congress, in Vienna, Austria, 28 September - 2 October.

24 Sep 2012

Many survivors of young adult cancers avoid routine medical care due to cost barriers

Many survivors of adolescent and young adult cancers avoid routine medical care because it's too expensive, despite the fact that most have health insurance.

24 Sep 2012

University of Copenhagen professors receive 2012 Carlsberg Foundations Research Prize

The Carlsberg Foundations Research Prizes 2012 goes to Professor in molecular biology Kristian Helin and Professor in international politics Ole W-ver. Each researcher receives 1 million DKK where - should be spend on further research.

24 Sep 2012

MD Anderson introduces Moon Shots Program to reduce cancer deaths

The University of Texas MD Anderson Cancer Center announces the launch of the Moon Shots Program, an unprecedented effort to dramatically accelerate the pace of converting scientific discoveries into clinical advances that reduce cancer deaths.

21 Sep 2012

PNAS: Ras proteins bring tension to the phosphate chain

Proteins accelerate certain chemical reactions in cells by several orders of magnitude. The molecular mechanism by which the Ras protein accelerates the cleavage of the molecule GTP and thus slows cell growth is described by biophysicists at the Ruhr-Universit-t Bochum led by Prof. Dr. Klaus Gerwert in the Online Early Edition of the journal PNAS.

20 Sep 2012

UC San Diego’s bold plan aims to personalize cancer treatment

UC San Diego Moores Cancer Center launched a bold plan today aimed at personalizing cancer treatment. The "My Answer to Cancer" team of oncologists, bioinformaticians, pathologists and geneticists pledges to "sequence" or analyze the DNA of large numbers of patients with cancer in order to match each patient to the best available drug for his or her particular tumor.

19 Sep 2012

Abiraterone acetate confirmed to offer significant survival benefit to advanced prostate cancer patients

Results of a phase 3 trial published in The Lancet Oncology have confirmed that the drug abiraterone acetate (marketed as Zytiga®) offers a significant survival benefit to patients with castration-resistant prostate cancer, which is spreading to other parts of their body (known as metastatic prostate cancer).

18 Sep 2012

CINJ experts available to discuss prevention and treatment of breast cancer

The Cancer Institute of New Jersey (CINJ) is making experts available to discuss the risks, and options for treatment and prevention surrounding breast cancer. According to the American Cancer Society 227,000 women nationwide will be diagnosed with the disease this year, and while the disease affects mostly women, men also can be diagnosed with breast cancer.

15 Sep 2012

Scientists describe how DNA origami can enhance effect of cytostatics in cancer treatment

Scientists at Karolinska Institutet in Sweden describe in a new study how so-called DNA origami can enhance the effect of certain cytostatics used in the treatment of cancer. With the aid of modern nanotechnology, scientists can target drugs direct to the tumour while leaving surrounding healthy tissue untouched.

14 Sep 2012

Solubilized curcumin shrinks lung tumors in mice

Belgian researchers report that orally administered curcumin can reduce the size of lung cancer tumors in mice.

13 Sep 2012

Predicting breast cancer drug response by 20/20 GeneSystems’ PredicTOR test

20/20 GeneSystems, Inc. will present results this week at the Breast Cancer Symposium 2012 (San Francisco) of a 45 patient study showing the usefulness of its PredicTOR test in predicting response of breast tumors to the drug Herceptin.

13 Sep 2012

Changes in physical characteristics of regulatory T cell can predict MDS progression risk

Researchers at Moffitt Cancer Center and colleagues have discovered that changes in the physical characteristics of the effector memory regulatory T cell can predict the progression risk of myelodysplastic syndromes (MDS) to acute myeloid leukemia. The finding could improve prognostication for patients with MDS and better inform therapeutic decision making.

13 Sep 2012

Blood pressure, oxygen saturation predict death in terminally ill

The most reliable events that predict impending death in terminally ill cancer patients being treated palliatively are decreased blood pressure and low oxygen saturation, show study results.

12 Sep 2012

Cancer Therapy News and Research

Lifestyle changes can play a considerable role in influencing risk of cancer later in life

PsiOxus initiates ColoAd1 phase I/II trial in metastatic solid tumours

IV connectors can play a crucial role in protecting patients from infections and other complications

ProMedica invests $710,000 in new cancer and infusion center in Fostoria, Ohio

Cancer-related medical costs to more than double in some states in less than eight years

Aromatase inhibitors impact sex life of postmenopausal women with breast cancer

Endorectal MRI helps assess eligibility of men with prostate cancer for active surveillance

ESMO Designated Center of Integrated Oncology and Palliative Care accreditation for 16 new centers

Many survivors of young adult cancers avoid routine medical care due to cost barriers

University of Copenhagen professors receive 2012 Carlsberg Foundations Research Prize

MD Anderson introduces Moon Shots Program to reduce cancer deaths

PNAS: Ras proteins bring tension to the phosphate chain

UC San Diego’s bold plan aims to personalize cancer treatment

Abiraterone acetate confirmed to offer significant survival benefit to advanced prostate cancer patients

CINJ experts available to discuss prevention and treatment of breast cancer

Scientists describe how DNA origami can enhance effect of cytostatics in cancer treatment

Solubilized curcumin shrinks lung tumors in mice

Predicting breast cancer drug response by 20/20 GeneSystems’ PredicTOR test

Changes in physical characteristics of regulatory T cell can predict MDS progression risk

Blood pressure, oxygen saturation predict death in terminally ill

Event guide: 7th Allogeneic Cell Therapies Summit eBook

Advancing Neuroscience Research Through Collaboration and Patient-Centered Innovation

The impact of vibration on microscopy

How Omics Technologies Are Transforming Biological Research and Drug Discovery

Latest News